Exome Asset Management LLC 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Exome Asset Management LLC disclosed 58 US equity positions worth $132.9m in its Q4 2024 13F filing. The largest position was BBIO at 5.1% of the reported book, followed by LLY and GERN. Against the Q3 2024 filing, it opened 19 new positions, added to 12 and reduced 13 among the top 50 holdings.
What did Exome Asset Management LLC own in Q4 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 5.1% | $6.8m | 246,700 | 17% | added |
| 2 | LLY ELI LILLY & CO | Healthcare | 4.8% | $6.4m | 8,247 | -21% | reduced |
| 3 | GERN GERON CORP | Healthcare | 4.2% | $5.6m | 1,561,152 | 72% | added |
| 4 | HUM HUMANA INC | Healthcare | 3.4% | $4.6m | 18,066 | – | new |
| 5 | GH GUARDANT HEALTH INC | Healthcare | 3.4% | $4.5m | 147,800 | 65% | added |
| 6 | RLAY RELAY THERAPEUTICS INC | Healthcare | 3.4% | $4.5m | 1,083,487 | 161% | added |
| 7 | IRON DISC MEDICINE INC | Healthcare | 3.3% | $4.4m | 69,072 | 7% | added |
| 8 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 3.2% | $4.2m | 318,900 | – | new |
| 9 | ARVN ARVINAS INC | Healthcare | 3.2% | $4.2m | 218,700 | – | new |
| 10 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 3.1% | $4.1m | 151,965 | 26% | added |
| 11 | ISRG INTUITIVE SURGICAL INC | Healthcare | 2.9% | $3.9m | 7,427 | 0% | held |
| 12 | APLSUSD APELLIS PHARMACEUTICALS INC | 2.9% | $3.8m | 119,467 | 19% | added | |
| 13 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 2.8% | $3.7m | 65,200 | -16% | reduced |
| 14 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 2.7% | $3.6m | 40,500 | – | new |
| 15 | NTRA NATERA INC | Healthcare | 2.7% | $3.6m | 22,450 | 0% | held |
| 16 | SLNOEUR SOLENO THERAPEUTICS INC | 2.6% | $3.5m | 77,285 | – | new | |
| 17 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 2.5% | $3.3m | 77,439 | -42% | reduced |
| 18 | NUVALENT INC | 2.4% | $3.2m | 40,580 | 103% | added | |
| 19 | CYTK CYTOKINETICS INC | Healthcare | 2.3% | $3.1m | 65,883 | 12% | added |
| 20 | 2655787D BLUEPRINT MEDICINES CORP | 2.1% | $2.8m | 31,800 | -13% | reduced | |
| 21 | GILD GILEAD SCIENCES INC | Healthcare | 2.1% | $2.7m | 29,700 | -41% | reduced |
| 22 | SMMT SUMMIT THERAPEUTICS INC | Healthcare | 1.8% | $2.3m | 130,412 | – | new |
| 23 | CNTA CENTESSA PHARMACEUTICALS PLC | 1.7% | $2.3m | 137,716 | -0% | held | |
| 24 | EWTX EDGEWISE THERAPEUTICS INC | 1.6% | $2.2m | 81,473 | 36% | added | |
| 25 | JANX JANUX THERAPEUTICS INC | Healthcare | 1.6% | $2.1m | 40,123 | – | new |
| 26 | SVRA SAVARA INC | Healthcare | 1.6% | $2.1m | 699,698 | – | new |
| 27 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 1.6% | $2.1m | 61,367 | – | new |
| 28 | PEN PENUMBRA INC | Healthcare | 1.6% | $2.1m | 9,000 | – | new |
| 29 | RCKT ROCKET PHARMACEUTICALS INC | Healthcare | 1.5% | $2.0m | 159,552 | – | new |
| 30 | AKERO THERAPEUTICS INC | 1.4% | $1.9m | 68,608 | -11% | reduced | |
| 31 | RDY DR REDDYS LABS LTD | Healthcare | 1.4% | $1.9m | 117,500 | 224% | added |
| 32 | ONC BEIGENE LTD | Healthcare | 1.4% | $1.8m | 10,000 | -35% | reduced |
| 33 | ETNBGBP 89BIO INC | 1.3% | $1.8m | 225,323 | -25% | reduced | |
| 34 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 1.2% | $1.6m | 28,178 | -38% | reduced |
| 35 | KARYOPHARM THERAPEUTICS INC | 1.2% | $1.6m | 2,000,000 | 0% | held | |
| 36 | PLRX PLIANT THERAPEUTICS INC | Healthcare | 1.0% | $1.4m | 103,504 | -31% | reduced |
| 37 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 1.0% | $1.3m | 283,599 | – | new |
| 38 | STOK STOKE THERAPEUTICS INC | Healthcare | 0.9% | $1.2m | 113,096 | -36% | reduced |
| 39 | LEGN LEGEND BIOTECH CORP | Healthcare | 0.9% | $1.2m | 37,600 | -20% | reduced |
| 40 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 0.9% | $1.2m | 26,081 | -28% | reduced |
| 41 | ALVOTECH | 0.9% | $1.2m | 90,100 | 0% | held | |
| 42 | MNLOUSD VYNE THERAPEUTICS INC | 0.9% | $1.2m | 353,434 | 0% | held | |
| 43 | ELDN ELEDON PHARMACEUTICALS INC | 0.8% | $1.1m | 256,373 | – | new | |
| 44 | BHVN BIOHAVEN LTD | Healthcare | 0.8% | $1.1m | 28,159 | – | new |
| 45 | GOSS GOSSAMER BIO INC | Healthcare | 0.7% | $993.2k | 1,097,999 | 134% | added |
| 46 | ACRS ACLARIS THERAPEUTICS INC | Healthcare | 0.7% | $965.5k | 389,333 | – | new |
| 47 | ANNX ANNEXON INC | Healthcare | 0.6% | $743.0k | 144,830 | – | new |
| 48 | VERU VERU INC | Healthcare | 0.6% | $739.5k | 1,117,600 | – | new |
| 49 | ACELYRIN INC | 0.6% | $736.1k | 234,435 | – | new | |
| 50 | REPL REPLIMUNE GROUP INC | Healthcare | 0.5% | $662.9k | 54,738 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.